Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population

Nutrition and Metabolism

Volumn 3, Issue , 2006, Pages

  Greene, Christine M ^a   Waters, David ^a   Clark, Richard M ^a   Contois, John H ^b   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b LIPOSCIENCE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTENOID; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; XANTHOPHYLL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CLINICAL ARTICLE; EGG; FEMALE; HUMAN; NUTRITIONAL REQUIREMENT; POSTMENOPAUSE;

EID: 33646149662     PISSN: 17437075     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-3-6     Document Type: Article

References (57)

1. Requejo AM, Ortega RM, Robles F, Navia B, Faci M, Aparicio A: Influence of nutrition on cognitive function in a group of elderly, independently living people. Eur J Clin Nutr 2003, 57 Suppl 1:S54-7.
2. Thorpe M: Strengthening the role of nutrition and improving the health of the elderly population. J Am Diet Assoc 2003, 103(3):337.
3. Flood KL, Carr DB: Nutrition in the elderly. Curr Opin Gastroenterol 2004, 20(2):125-129.
4. Song WO, Kerver JM: Nutritional contribution of eggs to American diets. J Am Coll Nutr 2000, 19(5 Suppl):556S-562S.
5. Carr AC, Frei B: Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999, 69(6):1086-1107.
6. Pryor WA: Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000, 28(1):141-164.
7. Riggs KM, Spiro A, Tucker K, Rush D: Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996, 63(3):306-314.
8. Ribaya-Mercado JD, Blumberg JB: Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr 2004, 23(6 Suppl):567S-587S.
9. Rock CL, Thornquist MD, Neuhouser ML, Kristal AR, Neumark-Sztainer D, Cooper DA, Patterson RE, Cheskin LJ: Diet and lifestyle correlates of lutein in the blood and diet. J Nutr 2002, 132(3):525S-530S.
10. Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ: Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998, 82(8):907-910.
11. Granado F, Olmedilla B, Blanco I: Nutritional and clinical relevance of lutein in human health. Br J Nutr 2003, 90(3):487-502.
12. Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB: Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am J Clin Nutr 1999, 70(2):247-251.
13. Nutrient Value of Eggs Eggs: Good Nutrition, Affordable Price [http://www.enc-online.org/eggnutr.htm].
14. Krauss RM, Deckelbaum RJ, Ernst N, Fisher E, Howard BV, Knopp RH, Kotchen T, Lichtenstein AH, McGill HC, Pearson TA, Prewitt TE, Stone NJ, Horn LV, Weinberg R: Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 1996, 94(7):1795-1800.
15. NCEP: Executive Summary: Report of the expert panel on population strategies for blood cholesterol reduction. In National Cholesterol Education Program Volume 151. Arch Intern Med; 1991:1071-1084.
16. Hu FB, Stampfer MJ, Rimm EB, Manson JE, Ascherio A, Colditz GA, Rosner BA, Spiegelman D, Speizer FE, Sacks FM, Hennekens CH, Willett WC: A prospective study of egg consumption and risk of cardiovascular disease in men and women. Jama 1999, 281(15):1387-1394.
17. Dawber TR, Nickerson RJ, Brand FN, Pool J: Eggs, serum cholesterol, and coronary heart disease. Am J Clin Nutr 1982, 36(4):617-625.
18. Kritchevsky SB: A review of scientific research and recommendations regarding eggs. J Am Coll Nutr 2004, 23(6 Suppl):596S-600S.
19. McNamara DJ: Predictions of plasma cholesterol responses to dietary cholesterol. Am J Clin Nutr 1985, 41(3):657-659.
20. McNamara DJ: Dietary cholesterol and atherosclerosis. Biochim Biophys Acta 2000, 1529(1-3):310-320.
21. Beynen AC, Katan MB: Human hypo- and hyper-responders to dietary cholesterol and fatty acids. In Recent Aspects of Diagnosis and Treatment of Lipoportein Disorders Impact of Prevention of Atherosclerotic Diseases New York, NY , Alan R. Liss; 1998:205-221.
22. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988, 260(13):1917-1921.
23. Tornvall P, Karpe F, Carlson LA, Hamsten A: Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991, 90(1):67-80.
24. Campos H, Genest JJJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992, 12(2):187-195.
25. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA: Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998, 18(7):1046-1053.
26. Rosenson RS, Otvos JD, Freedman DS: Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 2002, 90(2):89-94.
27. Johansson J, Carlson LA, Landou C, Hamsten A: High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991, 11(1):174-182.
28. Wilson HM, Patel JC, Russell D, Skinner ER: Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta 1993, 220(2):175-187.
29. Herron KL, Vega-Lopez S, Conde K, Ramjiganesh T, Roy S, Shachter NS, Fernandez ML: Pre-menopausal women, classified as hypoor hyperresponders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J Am Coll Nutr 2002, 21(3):250-258.
30. Greene CM, Zern TL, Wood RJ, Shrestha S, Aggarwal D, Sharman MJ, Volek JS, Fernandez ML: Maintenance of the LDL Cholesterol: HDL Cholesterol Ratio in an Elderly Population Given a Dietary Cholesterol Challenge. J Nutr 2005, 135(12):2793-2798.
31. Herron KL, Lofgren IE, Sharman M, Volek JS, Fernandez ML: High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification. Metabolism 2004, 53(6):823-830.
32. Berneis K, Rizzo M: LDL size: does it matter? Swiss Med Wkly 2004, 134(49-50):720-724.
33. "Expert Panel on Detection ETHBCA: Executive Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). 2001, 285:2486-2497.
34. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Jama 1996, 276(11):875-881.
35. St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Despres JP, Lamarche B: Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001, 104(19):2295-2299.
36. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH: A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996, 276(11):882-888.
37. Blake GJ, Otvos JD, Rifai N, Ridker PM: Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002, 106(15):1930-1937.
38. Lamarche B, St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Despres JP: A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol 2001, 17(8):859-865.
39. Beynen AC, Katan MB: Hypo- and hyperresponders to dietary cholesterol. Am J Clin Nutr 1986, 43(6):974-978.
40. Ballesteros MN, Cabrera RM, Saucedo Mdel S, Fernandez ML: Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico. Am J Clin Nutr 2004, 80(4):855-861.
41. Herron KL, Vega-Lopez S, Conde K, Ramjiganesh T, Shachter NS, Fernandez ML: Men classified as hypo- or hyperresponders to dietary cholesterol feeding exhibit differences in lipoprotein metabolism. J Nutr 2003, 133(4):1036-1042.
42. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20(4):470-475.
43. Carr TP, Andresen CJ, Rudel LL: Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 1993, 26(1):39-42.
44. Warnick GR, Benderson J, Albers JJ: Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28(6):1379-1388.
45. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
46. Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM: Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000, 71(6):1555-1562.
47. Otvos JD, Jeyarajah EJ, Bennett DW: Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991, 37(3):377-386.
48. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM: Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992, 38(9):1632-1638.
49. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PWF, Schaefer EJ: Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study. Clin Chem 2004, 50(7):1189-1200.
50. Stein O, Thiery J, Stein Y: Is there a genetic basis for resistance to atherosclerosis? Atherosclerosis 2002, 160(1):1-10.
51. Haffner SM, D'Agostino RJ, Goff D, Howard B, Festa A, Saad MF, Mykkanen L: LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999, 19(9):2234-2240.
52. Lamarche B, Lemieux I, Despres JP: The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 1999, 25(3):199-211.
53. Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M, Geshi E, Katagiri T: Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. Am Heart J 2002, 144(6):1026-1035.
54. Wilson HM, Patel JC, Skinner ER: The distribution of high-density lipoprotein subfractions in coronary survivors. Biochem Soc Trans 1990, 18(6):1175-1176.
55. Clevidence BA, Bieri JG: Association of carotenoids with human plasma lipoproteins. Methods Enzymol 1993, 214:33-46.
56. Parker RS: Absorption, metabolism, and transport of carotenoids. FASEB J 1996, 10(5):542-551.
57. Vogel S, Contois JH, Couch SC, Lammi-Keefe CJ: A rapid method for separation of plasma low and high density lipoproteins for tocopherol and carotenoid analyses. Lipids 1996, 31(4):421-426.